InoteveraGaidhi rinotevera
AI muWarehouse Robotics
Maindasitiri
MABHUKU EINDUSTRIES
Surgical robotics includes surgeon-controlled robotic-assisted systems and research on more autonomous tasks.
Teerera kugwaro iriAI-yakarondedzerwa · ~2 min
AI methods may process images or assist planning, but clinical capability depends on the specific device and study.
The da Vinci system is described by its manufacturer as surgeon-controlled robotic assistance. The STAR paper demonstrated supervised autonomous suturing of soft bowel tissue in animal models and describes stereo imaging, tissue-landmark detection and suture planning. The AVOID randomized phase 3 trial used ICG near-infrared fluorescence to assess bowel perfusion and adjust transection lines; its overall 90-day leakage rate was not significantly lower than conventional assessment. These examples do not establish universal autonomy or clinical benefit. In deformable-tissue surgery, tissue movement and visual constraints such as occlusion challenge image-based planning. The AVOID trial’s primary endpoint was clinically relevant anastomotic leakage within 90 days and showed no significant overall reduction with ICG fluorescence. The STAR animal study reports comparative consistency on specific measures including suture spacing and bite depth; it does not establish universal clinical superiority.
Intuitive describes da Vinci as a surgeon-controlled robotic-assisted system operated from a console.
The STAR research robot demonstrated supervised suturing of soft bowel tissue in animal models.
The STAR paper describes stereo imaging and tissue-landmark detection in its planning pipeline.
A randomized AVOID trial studied ICG near-infrared fluorescence for assessing bowel perfusion during colorectal surgery.
Research may test additional sensing and planning methods, but claims about clinical benefit, autonomy or regulatory expectations need evidence from a named device, study and jurisdiction. Preserving clinician oversight is presented here as a design recommendation.
Tsamba yemahara
Nhatu dzakasimbiswa dzeAI nyaya mangwanani ega ega pakati pevhiki, dzakanyorwa neChirungu chakajeka. Yemahara zvachose, hapana ads.
Imwe email zuva rega rega revhiki. Bvisa kunyoresa kamwe chete. Hatimbotengese kana kugovera kero yako.
Zviedze iwe pachako
Mhinduro yepakarepo pamhinduro yega yega, uye chitupa chinogovaniswa chine ID inobatika kana wapedza kosi.
Tsigira dzidzo yemahara yeAI. AI Understanding ndeye 501(c)(3) isingabatsiri - hapana ads, hapana paywall, zvachose. Ita chipo
Surgical robotics includes surgeon-controlled robotic-assisted systems and research on more autonomous tasks. AI methods may process images or assist planning, but clinical capability depends on the specific device and study.
Intuitive describes da Vinci as a surgeon-controlled robotic-assisted system. This is a manufacturer-described capability, not a prevalence claim.
Iyo Smart Tissue Autonomous Robot (STAR) yakasonanidzwa yakazvimisikidza matishu emudumbu munguruve, ichigadzira sutures dzakawanda kupfuura nyanzvi dzekuvhiya vanhu mukuratidzira kunoshamisa kwekuzvitonga kunotarisirwa.
Kusiyana nezvikamu zvakaomarara zvefekitari, tishu dzekuvhiya dzinogara dzichichinja chimiro uye dzakanyorova, dzinoratidzira, uye dzinowanzovanzwa nekubuda ropa, utsi hwe cautery, uye zviridzwa, zvichiita kuti zvikamu zvinovimbika uye kutevedza zviome.
The AVOID phase 3 trial reported no significant difference in overall 90-day clinically relevant leakage between fluorescence-guided and conventional groups. This is a study result, not a conclusion about every procedure or subgroup.
The randomized AVOID trial used ICG fluorescence to assess bowel perfusion and adjust or keep transection lines. It did not significantly reduce the overall 90-day leak rate in the studied population.
Ramba uchidzidza
Mamwe madhairekitori akasarudzirwa nyaya iyi
InoteveraGaidhi rinotevera
AI muWarehouse Robotics
Maindasitiri